MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations

O. Babkina, O. Levin, M. Poluektov (Moscow, Russian Federation)

Meeting: 2017 International Congress

Abstract Number: 101

Keywords: Excessive daytime sleepiness(EDS)

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To examine the frequency and risk factors of excessive daytime sleepiness (EDS) in patients with PD and to determine relationships between EDS and another symptoms of PD.

Background: EDS is a frequent symptom in PD and seems to be multifactorial by nature. The risk factors of EDS and associations with another symptoms are not enough investigated.

Methods: PD patients [N=32 (18M); 64,7±6,3 years old; 4,4±3,15 (0.3-12) years motor disease duration, HY range 1-3, and mean MoCA score 25.5±1.9 (22-29)] underwent clinical evaluation including the Epworth Sleepiness Scale (ESS) and the Parkinson’s disease sleep scale – 2 (PDSS-2), the Hoehn and Yahr scale and the MDS-Unified Parkinson’s disease rating scale (MDS-UPDRS), the Parkinson’s disease questionnaire (PDQ-39), Schwab and England Activities of Daily Living Rating (SE-ADL) and Hospital anxiety and depression scale (HADS). EDS was diagnosed according to the ESS, cutoff score above 10 was applied. All patients with EDS underwent one-night video-polysomnography study and the multiple sleep latency test (MSLT).

Results: 50% of patients had EDS. Baseline characteristics were similar between patients with and without EDS. Patients with EDS had higher PDSS-2 score (p=0,002), more prominent autonomic dysfunction and cognitive impairment (p=0,01), worse quality of life and lower daytime activity (p<0,01). EDS was associated with higher levodopa equivalent dose (LED) (633,8 versus 280,0; p=0,002), longer duration of therapy and part I, II and total MDS-UPDRS higher score (p=0,01). The mean time of sleep was 6,7±1,1 hours, index of sleep quality was 76,2±12,7%. Patients had reduced amount of deep wave sleep and a lot of awakenings. 31% had obstructive sleep apnea (OSA), but mean oxygen saturation was 93,8±1,3. The mean sleep latency (SL) was 7,5±4,3 min. Correlation between the apnea-hypopnea index (AHI) and mean SL was not found.

Conclusions: E

EDS occurs in 50% of patients with PD and associated with higher MDS-UPDRS score, more frequent autonomic dysfunction, cognitive impairment, higher LED, lower quality of life and daytime activity. Patients with EDS have fragmented sleep, but sleep duration is sufficient. 31% of patients had AHI>5, that indicates a wide frequency of OSA in PD and a potential role in genesis of EDS. However, SL values in such patients and absence of oxygen desaturation profile of OSA suggest the “abortive” OSA.

To cite this abstract in AMA style:

O. Babkina, O. Levin, M. Poluektov. Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/excessive-daytime-sleepiness-in-parkinsons-disease-risk-factors-and-clinical-associations/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/excessive-daytime-sleepiness-in-parkinsons-disease-risk-factors-and-clinical-associations/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley